In November xxxx, the Erucic Acid market saw a slight dip in prices, primarily driven by a reduction in both demand and consumption across the European region. This decrease in market activity was compounded by a decline in production costs, which further applied downward pressure on Erucic Acid prices.
The demand for Erucic Acid fell slightly from the cosmetics manufacturers. Advancements in safety testing within the European cosmetics sector, particularly through the Next Generation Risk Assessment (NGRA) framework, have impacted the demand for ingredients like Erucic Acid. As the industry increasingly prioritized ethical and reliable safety assessments, including Erucic Acid, which raised concerns about toxicity and safety, came under closer scrutiny. With new in vitro and computational models providing more precise evaluations, the demand for Erucic Acid in cosmetics declined, especially as safer alternatives were identified. The industry&#xx;s shift toward using well-assessed, non-toxic ingredients in response to...
